ACTONEL 35 MG TABLET

Risedronate Sodium
$81.8555per EA
High Outlier

Strength

30.1; 4.9 mg/1; mg/1

Manufacturer

Allergan, Inc.

NDC

00430047203

Classification

Brand

Dosage Form

TABLET, FILM COATED

Route

ORAL

Last Updated

1/21/2026

Approval Type

New Drug (NDA)

FDA Application

NDA020835

On Market Since

5/17/2002

Pharmacological Classes

Bisphosphonate
Bisphosphonate
Diphosphonates
Diphosphonates

Price History

1W

0.0%

1M

0.0%

3M

0.0%

6M

+0.1%

1Y

+0.4%

3Y

+0.2%

5Y

+0.2%

All

+132.3%